ABBOTT LABORATORIES SG&A Expense 2007-2025 | ABT
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is ABBOTT LABORATORIES's current sg&a expense?
ABBOTT LABORATORIES (ABT) annual sg&a expense for 2024 was $11.70B, a 6.83% increase from 2023. ABBOTT LABORATORIES sg&a expense for the quarter ending September 30, 2025 was $3.05B.
What was ABBOTT LABORATORIES's sg&a expense in 2023?
ABBOTT LABORATORIES annual sg&a expense for 2023 was $10.95B, a 2.66% decline from 2022.
What was ABBOTT LABORATORIES's sg&a expense in 2022?
ABBOTT LABORATORIES annual sg&a expense for 2022 was $11.25B, a 0.67% decline from 2021.
What is ABBOTT LABORATORIES's 5-year sg&a expense CAGR?
ABBOTT LABORATORIES sg&a expense grew at a compound annual growth rate (CAGR) of 3.68% from FY2019 to FY2024, going from $9.77B to $11.70B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.7%
FY2019
$9.77B
→
FY2024
$11.70B
070809101112131415161718192021222324
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $11.70B | +6.8% | 10-K |
| FY2023 | $10.95B | -2.7% | 10-K |
| FY2022 | $11.25B | -0.7% | 10-K |
| FY2021 | $11.32B | +16.8% | 10-K |
| FY2020 | $9.70B | -0.7% | 10-K |
| FY2019 | $9.77B | +0.2% | 10-K |
| FY2018 | $9.74B | +6.1% | 10-K |
| FY2017 | $9.18B | +36.3% | 10-K |
| FY2016 | $6.74B | -0.7% | 10-K |
| FY2015 | $6.79B | +3.9% | 10-K |
| FY2014 | $6.53B | +2.5% | 10-K |
| FY2013 | $6.37B | -5.4% | 10-K |
| FY2012 | $6.74B | -8.6% | 10-K |
| FY2011 | $7.37B | -29.0% | 10-K |
| FY2010 | $10.38B | +23.4% | 10-K |
| FY2009 | $8.41B | -0.4% | 10-K |
| FY2008 | $8.44B | +13.9% | 10-K |
| FY2007 | $7.41B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →